Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxd1
|
ENSMUSG00000078302.3 | forkhead box D1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_98354370_98354731 | Foxd1 | 308 | 0.867326 | -0.67 | 1.7e-08 | Click! |
chr13_98354125_98354312 | Foxd1 | 24 | 0.970172 | -0.67 | 1.8e-08 | Click! |
chr13_98354971_98355147 | Foxd1 | 817 | 0.556113 | -0.53 | 2.9e-05 | Click! |
chr13_98353838_98354008 | Foxd1 | 319 | 0.860513 | -0.51 | 6.7e-05 | Click! |
chr13_98355225_98355376 | Foxd1 | 1058 | 0.451726 | -0.46 | 3.7e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_51039988_51040153 | 13.34 |
Gm40319 |
predicted gene, 40319 |
12311 |
0.29 |
chr4_151773758_151773918 | 12.66 |
Camta1 |
calmodulin binding transcription activator 1 |
87812 |
0.08 |
chr2_167431166_167431353 | 12.15 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
7140 |
0.18 |
chr8_23053611_23053959 | 11.99 |
Ank1 |
ankyrin 1, erythroid |
4474 |
0.2 |
chr4_130715764_130715925 | 11.77 |
Snord85 |
small nucleolar RNA, C/D box 85 |
33790 |
0.11 |
chr5_123223029_123223358 | 11.75 |
Psmd9 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
4997 |
0.12 |
chr9_50692728_50692943 | 11.03 |
Dixdc1 |
DIX domain containing 1 |
964 |
0.45 |
chr1_185472844_185473015 | 10.88 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
14365 |
0.12 |
chr5_123201506_123201803 | 10.82 |
Gm43409 |
predicted gene 43409 |
10066 |
0.1 |
chr17_86313458_86313775 | 10.04 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
26438 |
0.23 |
chr2_131213938_131214219 | 10.00 |
Ap5s1 |
adaptor-related protein 5 complex, sigma 1 subunit |
3474 |
0.13 |
chr2_72908187_72908356 | 9.83 |
Sp3 |
trans-acting transcription factor 3 |
32813 |
0.14 |
chr2_152817573_152818379 | 9.61 |
Bcl2l1 |
BCL2-like 1 |
10559 |
0.12 |
chr1_166002288_166003185 | 9.32 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr2_132695735_132696027 | 9.10 |
Shld1 |
shieldin complex subunit 1 |
2238 |
0.17 |
chr3_121346684_121346842 | 8.99 |
Gm5711 |
predicted gene 5711 |
33916 |
0.12 |
chr11_32293637_32293804 | 8.94 |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
2769 |
0.15 |
chr4_41387869_41388043 | 8.93 |
Ubap1 |
ubiquitin-associated protein 1 |
16231 |
0.12 |
chr10_41241135_41241338 | 8.92 |
Gm25526 |
predicted gene, 25526 |
25191 |
0.16 |
chr2_163586914_163587109 | 8.90 |
Ttpal |
tocopherol (alpha) transfer protein-like |
15303 |
0.13 |
chr6_57767497_57767835 | 8.87 |
Vopp1 |
vesicular, overexpressed in cancer, prosurvival protein 1 |
56974 |
0.07 |
chr2_15163820_15164009 | 8.87 |
Gm13313 |
predicted gene 13313 |
36314 |
0.17 |
chr3_89136366_89136871 | 8.87 |
Pklr |
pyruvate kinase liver and red blood cell |
5 |
0.94 |
chr9_107971568_107971739 | 8.85 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
3852 |
0.07 |
chr1_172903375_172903674 | 8.75 |
Apcs |
serum amyloid P-component |
8483 |
0.16 |
chr4_130295074_130295364 | 8.66 |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
13376 |
0.13 |
chr1_161792976_161793173 | 8.62 |
Fasl |
Fas ligand (TNF superfamily, member 6) |
4579 |
0.16 |
chr11_30997075_30997232 | 8.60 |
Gm12102 |
predicted gene 12102 |
6745 |
0.17 |
chr11_20916554_20916845 | 8.56 |
Gm23681 |
predicted gene, 23681 |
21002 |
0.18 |
chr11_69062573_69063351 | 8.54 |
9330160F10Rik |
RIKEN cDNA 9330160F10 gene |
2479 |
0.1 |
chr10_80858382_80858558 | 8.52 |
Sppl2b |
signal peptide peptidase like 2B |
1349 |
0.2 |
chr6_5156932_5157313 | 8.40 |
Pon1 |
paraoxonase 1 |
36641 |
0.14 |
chr7_83885959_83886110 | 8.33 |
Mesd |
mesoderm development LRP chaperone |
1568 |
0.21 |
chr15_6059468_6059633 | 8.27 |
Gm8047 |
predicted gene 8047 |
24589 |
0.23 |
chr5_110836375_110836537 | 8.25 |
Hscb |
HscB iron-sulfur cluster co-chaperone |
136 |
0.93 |
chrX_139596463_139596745 | 8.12 |
Rnf128 |
ring finger protein 128 |
14016 |
0.22 |
chr15_78413114_78413438 | 8.04 |
Mpst |
mercaptopyruvate sulfurtransferase |
3294 |
0.12 |
chr17_6804856_6805157 | 8.03 |
4933426B08Rik |
RIKEN cDNA 4933426B08 gene |
3503 |
0.19 |
chr19_32476101_32476290 | 7.99 |
Minpp1 |
multiple inositol polyphosphate histidine phosphatase 1 |
9574 |
0.14 |
chr7_98048253_98048538 | 7.99 |
Myo7a |
myosin VIIA |
16807 |
0.21 |
chr6_83014860_83015022 | 7.99 |
M1ap |
meiosis 1 associated protein |
11397 |
0.07 |
chr3_145590943_145591292 | 7.91 |
Znhit6 |
zinc finger, HIT type 6 |
4751 |
0.23 |
chr11_107992099_107992280 | 7.87 |
Gm11657 |
predicted gene 11657 |
1833 |
0.29 |
chr1_179854274_179854595 | 7.84 |
Ahctf1 |
AT hook containing transcription factor 1 |
50754 |
0.12 |
chr1_86479174_86479713 | 7.83 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr3_153807931_153808101 | 7.80 |
5730460C07Rik |
RIKEN cDNA 5730460C07 gene |
15929 |
0.1 |
chr19_29066936_29067376 | 7.71 |
Gm9895 |
predicted gene 9895 |
191 |
0.91 |
chr6_57513454_57513639 | 7.60 |
Ppm1k |
protein phosphatase 1K (PP2C domain containing) |
2061 |
0.25 |
chr2_29677911_29678077 | 7.58 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
24488 |
0.15 |
chr10_81382117_81382333 | 7.58 |
Dohh |
deoxyhypusine hydroxylase/monooxygenase |
2203 |
0.09 |
chr11_20636524_20636686 | 7.57 |
Sertad2 |
SERTA domain containing 2 |
4626 |
0.25 |
chr16_49896195_49896504 | 7.55 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
29516 |
0.24 |
chr15_59047713_59048081 | 7.53 |
Mtss1 |
MTSS I-BAR domain containing 1 |
7300 |
0.23 |
chr8_45262021_45262194 | 7.51 |
F11 |
coagulation factor XI |
76 |
0.97 |
chr12_30908463_30908620 | 7.48 |
Acp1 |
acid phosphatase 1, soluble |
3008 |
0.22 |
chr6_120011639_120011795 | 7.38 |
Gm16199 |
predicted gene 16199 |
5719 |
0.18 |
chr13_112043565_112043865 | 7.33 |
Gm15323 |
predicted gene 15323 |
38213 |
0.15 |
chr1_151741165_151741489 | 7.32 |
2810414N06Rik |
RIKEN cDNA 2810414N06 gene |
13691 |
0.18 |
chr4_120346306_120346458 | 7.30 |
Foxo6os |
forkhead box O6, opposite strand |
55032 |
0.12 |
chr18_10036244_10036397 | 7.30 |
Usp14 |
ubiquitin specific peptidase 14 |
6179 |
0.19 |
chr13_119232734_119232969 | 7.29 |
Gm44488 |
predicted gene, 44488 |
36753 |
0.17 |
chr2_130655785_130655966 | 7.25 |
Ddrgk1 |
DDRGK domain containing 1 |
1098 |
0.34 |
chr5_143819015_143819332 | 7.21 |
Eif2ak1 |
eukaryotic translation initiation factor 2 alpha kinase 1 |
1226 |
0.42 |
chr6_34412159_34412311 | 7.19 |
Akr1b7 |
aldo-keto reductase family 1, member B7 |
99 |
0.95 |
chr8_3256601_3256763 | 7.13 |
Gm16180 |
predicted gene 16180 |
3022 |
0.26 |
chr14_32168431_32168589 | 7.10 |
Ncoa4 |
nuclear receptor coactivator 4 |
2235 |
0.18 |
chr16_90822274_90822555 | 7.09 |
Eva1c |
eva-1 homolog C (C. elegans) |
4305 |
0.16 |
chr5_146307212_146307364 | 7.06 |
Cdk8 |
cyclin-dependent kinase 8 |
10923 |
0.17 |
chr6_28232245_28232573 | 7.05 |
Gm42548 |
predicted gene 42548 |
4604 |
0.16 |
chr10_93891123_93891291 | 7.04 |
Metap2 |
methionine aminopeptidase 2 |
5 |
0.97 |
chr9_119164891_119165085 | 7.04 |
Gm10608 |
predicted gene 10608 |
2258 |
0.18 |
chr11_11841342_11841508 | 7.02 |
Ddc |
dopa decarboxylase |
5145 |
0.2 |
chr6_13052400_13052710 | 7.01 |
Gm5300 |
predicted gene 5300 |
4042 |
0.25 |
chr9_50693283_50693436 | 7.01 |
Dixdc1 |
DIX domain containing 1 |
440 |
0.75 |
chr6_34157215_34157595 | 7.01 |
Gm13856 |
predicted gene 13856 |
5476 |
0.19 |
chr1_75190714_75190906 | 7.01 |
Atg9a |
autophagy related 9A |
428 |
0.55 |
chr6_80555113_80555264 | 6.97 |
Gm44242 |
predicted gene, 44242 |
40594 |
0.19 |
chr7_123420015_123420410 | 6.96 |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
2069 |
0.31 |
chrX_75102403_75102554 | 6.94 |
Gm25520 |
predicted gene, 25520 |
1069 |
0.31 |
chr3_103196290_103196441 | 6.94 |
2410024N13Rik |
RIKEN cDNA 2410024N13 gene |
2610 |
0.2 |
chr5_117365976_117366161 | 6.93 |
Wsb2 |
WD repeat and SOCS box-containing 2 |
2546 |
0.16 |
chr5_139734496_139734696 | 6.92 |
Micall2 |
MICAL-like 2 |
1740 |
0.28 |
chr2_18969128_18969574 | 6.91 |
Pip4k2a |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
28775 |
0.18 |
chr4_126990673_126990824 | 6.88 |
Gm12939 |
predicted gene 12939 |
7309 |
0.13 |
chr1_88044901_88045120 | 6.87 |
AC087801.1 |
UDP glycosyltransferase 1 family (Ytg1) pseudogene |
7410 |
0.08 |
chr11_58916994_58917203 | 6.87 |
Btnl10 |
butyrophilin-like 10 |
810 |
0.34 |
chr10_4625371_4625599 | 6.84 |
Esr1 |
estrogen receptor 1 (alpha) |
13464 |
0.23 |
chr11_31835463_31835626 | 6.82 |
Gm12107 |
predicted gene 12107 |
2884 |
0.26 |
chr2_178471923_178472101 | 6.72 |
Cdh26 |
cadherin-like 26 |
11382 |
0.22 |
chr6_117297990_117298197 | 6.71 |
Rpl28-ps4 |
ribosomal protein L28, pseudogene 4 |
84027 |
0.08 |
chr16_4559726_4560765 | 6.70 |
Tfap4 |
transcription factor AP4 |
391 |
0.8 |
chr8_33981022_33981341 | 6.67 |
Gm39157 |
predicted gene, 39157 |
4733 |
0.18 |
chr12_111896884_111897036 | 6.66 |
Ppp1r13b |
protein phosphatase 1, regulatory subunit 13B |
10659 |
0.12 |
chr4_33465930_33466104 | 6.63 |
Gm11935 |
predicted gene 11935 |
13128 |
0.22 |
chr8_72413637_72413811 | 6.63 |
Eps15l1 |
epidermal growth factor receptor pathway substrate 15-like 1 |
7714 |
0.1 |
chr9_3328190_3328384 | 6.62 |
Alkbh8 |
alkB homolog 8, tRNA methyltransferase |
6853 |
0.19 |
chr3_100429656_100429868 | 6.62 |
4930406D18Rik |
RIKEN cDNA 4930406D18 gene |
3323 |
0.19 |
chr9_25550384_25550547 | 6.59 |
Gm25861 |
predicted gene, 25861 |
11260 |
0.2 |
chr6_29267024_29267197 | 6.58 |
Hilpda |
hypoxia inducible lipid droplet associated |
5378 |
0.13 |
chr5_129742979_129743345 | 6.57 |
Nipsnap2 |
nipsnap homolog 2 |
9496 |
0.1 |
chr12_91384738_91384923 | 6.57 |
Tshr |
thyroid stimulating hormone receptor |
264 |
0.65 |
chr6_87583790_87584040 | 6.54 |
Prokr1 |
prokineticin receptor 1 |
6804 |
0.14 |
chr2_147942665_147942870 | 6.50 |
9030622O22Rik |
RIKEN cDNA 9030622O22 gene |
33418 |
0.18 |
chr18_23710155_23710339 | 6.49 |
Gm15972 |
predicted gene 15972 |
42058 |
0.12 |
chr1_194482754_194482920 | 6.48 |
Plxna2 |
plexin A2 |
135381 |
0.05 |
chr13_112833681_112833853 | 6.48 |
Plpp1 |
phospholipid phosphatase 1 |
32904 |
0.12 |
chr1_171224939_171225126 | 6.45 |
Apoa2 |
apolipoprotein A-II |
22 |
0.93 |
chr8_109865208_109865726 | 6.43 |
Ap1g1 |
adaptor protein complex AP-1, gamma 1 subunit |
2359 |
0.17 |
chr19_6300372_6300856 | 6.40 |
Ehd1 |
EH-domain containing 1 |
2700 |
0.11 |
chr11_30166306_30166594 | 6.38 |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
31807 |
0.19 |
chr10_86356933_86357102 | 6.38 |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
54163 |
0.11 |
chr6_14185920_14186504 | 6.35 |
Gm23760 |
predicted gene, 23760 |
72896 |
0.11 |
chr3_21986227_21986389 | 6.35 |
Gm43674 |
predicted gene 43674 |
12160 |
0.21 |
chr11_46078060_46078305 | 6.34 |
Adam19 |
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
22124 |
0.11 |
chr3_108096711_108096990 | 6.34 |
Gnat2 |
guanine nucleotide binding protein, alpha transducing 2 |
393 |
0.71 |
chr18_62180293_62180673 | 6.32 |
Gm9949 |
predicted gene 9949 |
357 |
0.62 |
chr5_72857890_72858058 | 6.31 |
Tec |
tec protein tyrosine kinase |
10422 |
0.16 |
chr16_90779900_90780106 | 6.30 |
Urb1 |
URB1 ribosome biogenesis 1 homolog (S. cerevisiae) |
7212 |
0.16 |
chr1_79466636_79466862 | 6.30 |
Scg2 |
secretogranin II |
26629 |
0.18 |
chr18_12810835_12811052 | 6.29 |
Osbpl1a |
oxysterol binding protein-like 1A |
8655 |
0.18 |
chr13_47170791_47171101 | 6.29 |
Gm48581 |
predicted gene, 48581 |
15938 |
0.14 |
chrX_164424937_164425104 | 6.29 |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
490 |
0.78 |
chr8_83405652_83405829 | 6.27 |
Clgn |
calmegin |
15862 |
0.13 |
chr7_75611639_75612062 | 6.25 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
10 |
0.98 |
chr12_102787968_102788326 | 6.24 |
Gm47042 |
predicted gene, 47042 |
23435 |
0.08 |
chr12_83427791_83427951 | 6.23 |
Dpf3 |
D4, zinc and double PHD fingers, family 3 |
12049 |
0.23 |
chr18_24102564_24102822 | 6.22 |
Ino80c |
INO80 complex subunit C |
12220 |
0.18 |
chr4_116097242_116097555 | 6.21 |
Rad54l |
RAD54 like (S. cerevisiae) |
2660 |
0.15 |
chr4_131041217_131041368 | 6.20 |
A930031H19Rik |
RIKEN cDNA A930031H19 gene |
30818 |
0.18 |
chr16_18430514_18430668 | 6.20 |
Txnrd2 |
thioredoxin reductase 2 |
1666 |
0.22 |
chr4_48315003_48315157 | 6.19 |
Gm12435 |
predicted gene 12435 |
30150 |
0.16 |
chr1_36214420_36214590 | 6.18 |
Uggt1 |
UDP-glucose glycoprotein glucosyltransferase 1 |
4475 |
0.2 |
chr2_129215261_129215440 | 6.13 |
A730036I17Rik |
RIKEN cDNA A730036I17 gene |
3619 |
0.11 |
chr16_21355794_21355945 | 6.09 |
Magef1 |
melanoma antigen family F, 1 |
22513 |
0.18 |
chr10_37231291_37231825 | 6.08 |
4930543K20Rik |
RIKEN cDNA 4930543K20 gene |
32190 |
0.19 |
chr11_67722541_67722704 | 6.03 |
Rcvrn |
recoverin |
27296 |
0.14 |
chr5_97834809_97835101 | 6.02 |
Antxr2 |
anthrax toxin receptor 2 |
161140 |
0.03 |
chr12_110024246_110024718 | 6.01 |
Gm34667 |
predicted gene, 34667 |
609 |
0.65 |
chr5_34924526_34924867 | 6.01 |
Msantd1 |
Myb/SANT-like DNA-binding domain containing 1 |
7157 |
0.18 |
chr7_120980000_120980353 | 6.00 |
Cdr2 |
cerebellar degeneration-related 2 |
1614 |
0.22 |
chr11_107469708_107471023 | 6.00 |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
334 |
0.82 |
chr9_70011195_70011400 | 5.99 |
Gtf2a2 |
general transcription factor II A, 2 |
1253 |
0.38 |
chr4_134759700_134760317 | 5.99 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
8016 |
0.2 |
chr7_73517907_73518068 | 5.99 |
C130083A15Rik |
RIKEN cDNA C130083A15 gene |
10738 |
0.11 |
chr4_134751606_134751882 | 5.98 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
894 |
0.61 |
chr13_109652180_109652468 | 5.98 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
19544 |
0.3 |
chr3_122247630_122247781 | 5.96 |
Gclm |
glutamate-cysteine ligase, modifier subunit |
1624 |
0.21 |
chr19_42583808_42583967 | 5.95 |
R3hcc1l |
R3H domain and coiled-coil containing 1 like |
2726 |
0.25 |
chr16_35981055_35981219 | 5.94 |
Gm15564 |
predicted gene 15564 |
4 |
0.96 |
chr4_49148817_49148968 | 5.94 |
Plppr1 |
phospholipid phosphatase related 1 |
89436 |
0.08 |
chr14_41007337_41007980 | 5.94 |
Prxl2a |
peroxiredoxin like 2A |
608 |
0.7 |
chr4_19719896_19720047 | 5.93 |
Gm12354 |
predicted gene 12354 |
85 |
0.98 |
chr11_75637667_75638005 | 5.91 |
Inpp5k |
inositol polyphosphate 5-phosphatase K |
1301 |
0.31 |
chr6_38343722_38344076 | 5.91 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
10374 |
0.13 |
chr1_23426721_23426903 | 5.91 |
Ogfrl1 |
opioid growth factor receptor-like 1 |
29040 |
0.17 |
chr5_149086855_149087006 | 5.88 |
Hmgb1 |
high mobility group box 1 |
33417 |
0.08 |
chr4_53131044_53131242 | 5.85 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
28752 |
0.18 |
chr10_118581520_118581685 | 5.85 |
Ifngas1 |
Ifng antisense RNA 1 |
25077 |
0.2 |
chr6_85908437_85908607 | 5.83 |
Tprkb |
Tp53rk binding protein |
3343 |
0.1 |
chr19_3333194_3333524 | 5.83 |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
366 |
0.81 |
chr2_91268697_91269043 | 5.83 |
Arfgap2 |
ADP-ribosylation factor GTPase activating protein 2 |
472 |
0.71 |
chr6_67162285_67162524 | 5.81 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
2520 |
0.24 |
chr6_30307301_30307482 | 5.80 |
1700095J07Rik |
RIKEN cDNA 1700095J07 gene |
2770 |
0.2 |
chr11_46370537_46370688 | 5.79 |
Itk |
IL2 inducible T cell kinase |
18845 |
0.13 |
chr1_187155725_187155876 | 5.79 |
Spata17 |
spermatogenesis associated 17 |
12703 |
0.15 |
chr6_84640633_84641008 | 5.79 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
46912 |
0.17 |
chr5_108454228_108454380 | 5.78 |
Mfsd7a |
major facilitator superfamily domain containing 7A |
5204 |
0.12 |
chr3_57424782_57424933 | 5.78 |
Tm4sf4 |
transmembrane 4 superfamily member 4 |
457 |
0.85 |
chr5_90414232_90414383 | 5.77 |
Gm43363 |
predicted gene 43363 |
17034 |
0.15 |
chr8_116540198_116540349 | 5.76 |
Dynlrb2 |
dynein light chain roadblock-type 2 |
35258 |
0.19 |
chr17_33718644_33719001 | 5.76 |
Marchf2 |
membrane associated ring-CH-type finger 2 |
152 |
0.91 |
chr11_109488104_109488259 | 5.75 |
Arsg |
arylsulfatase G |
2575 |
0.19 |
chr12_110230863_110231036 | 5.74 |
Gm40576 |
predicted gene, 40576 |
5413 |
0.13 |
chrX_143012415_143012575 | 5.73 |
Ammecr1 |
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
45767 |
0.15 |
chr2_52604368_52604541 | 5.72 |
Bloc1s2-ps |
biogenesis of lysosomal organelles complex-1, subunit 2, pseudogene |
15300 |
0.2 |
chr1_88206786_88207160 | 5.72 |
Dnajb3 |
DnaJ heat shock protein family (Hsp40) member B3 |
1191 |
0.22 |
chr1_181005432_181005739 | 5.71 |
Ephx1 |
epoxide hydrolase 1, microsomal |
9415 |
0.09 |
chr6_143067791_143067965 | 5.70 |
C2cd5 |
C2 calcium-dependent domain containing 5 |
793 |
0.63 |
chr15_30286330_30286481 | 5.68 |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
113267 |
0.06 |
chr4_136214938_136215135 | 5.67 |
Asap3 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3 |
8671 |
0.14 |
chr15_95897787_95897938 | 5.67 |
Gm25070 |
predicted gene, 25070 |
18045 |
0.17 |
chr1_154065944_154066223 | 5.66 |
Gm25336 |
predicted gene, 25336 |
14116 |
0.16 |
chr6_5154894_5155087 | 5.64 |
Pon1 |
paraoxonase 1 |
38773 |
0.14 |
chr15_58743876_58744227 | 5.64 |
Gm20712 |
predicted gene 20712 |
37900 |
0.14 |
chr12_116269265_116269416 | 5.62 |
Gm11027 |
predicted gene 11027 |
6046 |
0.13 |
chr13_52831701_52831898 | 5.61 |
BB123696 |
expressed sequence BB123696 |
74594 |
0.1 |
chr19_10822656_10822807 | 5.60 |
Cd6 |
CD6 antigen |
7125 |
0.11 |
chr8_93252681_93252835 | 5.59 |
Gm45727 |
predicted gene 45727 |
1583 |
0.3 |
chr7_4806720_4807013 | 5.58 |
Ube2s |
ubiquitin-conjugating enzyme E2S |
4253 |
0.09 |
chr7_103942867_103943027 | 5.56 |
Olfr633 |
olfactory receptor 633 |
1490 |
0.15 |
chr11_99045547_99045892 | 5.55 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
953 |
0.43 |
chr17_36020770_36020975 | 5.55 |
H2-T24 |
histocompatibility 2, T region locus 24 |
312 |
0.69 |
chr10_94567983_94568134 | 5.55 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
7199 |
0.17 |
chr3_131283865_131284016 | 5.55 |
Gm18492 |
predicted gene, 18492 |
1204 |
0.4 |
chr7_120969343_120969499 | 5.52 |
Cdr2 |
cerebellar degeneration-related 2 |
12369 |
0.1 |
chr8_11140606_11140895 | 5.51 |
Gm44717 |
predicted gene 44717 |
8496 |
0.16 |
chr6_136804007_136804603 | 5.51 |
H4f16 |
H4 histone 16 |
110 |
0.77 |
chr2_27624746_27625249 | 5.50 |
Rxra |
retinoid X receptor alpha |
51443 |
0.12 |
chr17_24848922_24849092 | 5.50 |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
1357 |
0.2 |
chr4_70531153_70531321 | 5.50 |
Megf9 |
multiple EGF-like-domains 9 |
3691 |
0.37 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
2.1 | 6.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.0 | 6.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.9 | 7.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.8 | 5.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.7 | 8.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.5 | 4.5 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.5 | 6.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.4 | 8.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.4 | 4.1 | GO:0008050 | female courtship behavior(GO:0008050) |
1.3 | 4.0 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
1.3 | 4.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.3 | 5.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
1.3 | 6.5 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
1.3 | 3.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
1.3 | 3.8 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.2 | 3.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.2 | 3.5 | GO:0042117 | monocyte activation(GO:0042117) |
1.2 | 4.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
1.1 | 8.0 | GO:0015825 | L-serine transport(GO:0015825) |
1.1 | 3.4 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.1 | 3.2 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.1 | 9.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
1.0 | 5.2 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.0 | 3.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.0 | 3.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
1.0 | 4.0 | GO:0008228 | opsonization(GO:0008228) |
1.0 | 5.0 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
1.0 | 3.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.0 | 3.9 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.0 | 3.9 | GO:0019532 | oxalate transport(GO:0019532) |
1.0 | 5.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.0 | 5.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
1.0 | 2.9 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
1.0 | 3.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
1.0 | 3.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.9 | 2.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.9 | 3.8 | GO:0003383 | apical constriction(GO:0003383) |
0.9 | 4.7 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.9 | 2.8 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.9 | 2.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.9 | 3.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.9 | 12.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.9 | 1.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.9 | 2.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.8 | 1.7 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.8 | 4.2 | GO:0015886 | heme transport(GO:0015886) |
0.8 | 2.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.8 | 0.8 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.8 | 4.9 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.8 | 5.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.8 | 7.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.8 | 4.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.8 | 7.1 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.8 | 4.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.8 | 3.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.8 | 2.3 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.8 | 2.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.8 | 2.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.7 | 3.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.7 | 2.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 2.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.7 | 5.8 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.7 | 2.9 | GO:0042023 | DNA endoreduplication(GO:0042023) |
0.7 | 2.2 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.7 | 2.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.7 | 2.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.7 | 2.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 1.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.7 | 2.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.7 | 4.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.7 | 2.1 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.7 | 1.4 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.7 | 2.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.7 | 2.6 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.7 | 3.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.7 | 2.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.6 | 1.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.6 | 1.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.6 | 1.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.6 | 4.4 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 1.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.6 | 1.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.6 | 1.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.6 | 4.8 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.6 | 3.0 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.6 | 3.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.6 | 1.8 | GO:0040031 | snRNA modification(GO:0040031) |
0.6 | 2.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.6 | 1.8 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.6 | 1.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.6 | 1.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 2.9 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.6 | 1.7 | GO:2000836 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.6 | 1.7 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.6 | 3.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 1.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 2.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.6 | 1.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 6.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.5 | 1.6 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.5 | 0.5 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.5 | 1.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.5 | 1.6 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 1.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 2.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.5 | 2.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 2.1 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.5 | 2.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 1.1 | GO:1904833 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.5 | 4.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.5 | 3.7 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.5 | 1.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.5 | 4.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.5 | 0.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.5 | 1.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 1.5 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 9.1 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 3.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.5 | 1.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 1.0 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.5 | 3.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 3.0 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.5 | 1.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 2.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.5 | 3.0 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.5 | 2.8 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.5 | 4.3 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.5 | 1.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.5 | 0.9 | GO:0035973 | aggrephagy(GO:0035973) |
0.4 | 1.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 2.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.4 | 1.3 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 1.3 | GO:0035425 | autocrine signaling(GO:0035425) |
0.4 | 1.3 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.4 | 1.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 1.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.4 | 1.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.4 | 1.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 4.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.4 | 1.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.4 | 1.7 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.4 | 3.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 1.3 | GO:0061511 | centriole elongation(GO:0061511) |
0.4 | 0.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.4 | 1.7 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.4 | 1.2 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 2.5 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.4 | 0.4 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.4 | 1.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.4 | 0.4 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.4 | 1.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.4 | 3.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.4 | 1.2 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.4 | 1.2 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.4 | 1.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.4 | 0.4 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.4 | 1.6 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.4 | 0.8 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.4 | 3.9 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 0.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.4 | 0.8 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 1.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 0.4 | GO:0060066 | oviduct development(GO:0060066) |
0.4 | 0.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 2.7 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 0.8 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 | 1.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 0.8 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 1.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 1.5 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 0.8 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.4 | 1.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.4 | 1.1 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 0.7 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.4 | 2.2 | GO:0032328 | alanine transport(GO:0032328) |
0.4 | 1.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.4 | 2.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 2.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.4 | 5.9 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.4 | 1.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.4 | 1.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.4 | 8.7 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.4 | 2.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 1.1 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.4 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 0.7 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 1.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.4 | 3.5 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.4 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.3 | 0.7 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
0.3 | 1.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.3 | 2.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 1.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.7 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 1.7 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.3 | 1.0 | GO:0036394 | amylase secretion(GO:0036394) |
0.3 | 2.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 0.3 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.3 | 1.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.3 | 1.0 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.3 | 3.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.3 | 3.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 1.0 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.3 | 1.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.3 | 2.0 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.3 | 1.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.3 | 1.6 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.3 | 0.6 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.3 | 0.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 0.6 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.3 | 0.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.3 | 4.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 1.3 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.3 | 0.3 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.3 | 0.9 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 0.9 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 0.9 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 2.5 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 0.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.3 | 0.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 0.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 1.9 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
0.3 | 2.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.3 | 0.3 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.3 | 2.1 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 0.9 | GO:0009411 | response to UV(GO:0009411) |
0.3 | 0.9 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.3 | 2.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.3 | 0.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 1.5 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.3 | 0.9 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.3 | 0.9 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.3 | 2.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.3 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 1.8 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.3 | 1.2 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.3 | 0.9 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 3.8 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.3 | 0.3 | GO:0042161 | regulation of lipoprotein oxidation(GO:0034442) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.3 | 1.2 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.3 | 0.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.3 | 0.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.3 | 1.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 0.9 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 1.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 0.6 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.3 | 1.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.3 | 2.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.3 | 0.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 1.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 1.4 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.3 | 1.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.3 | 0.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.3 | 3.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.3 | 1.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.3 | 0.8 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 0.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.3 | 0.8 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.3 | 3.5 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.3 | 1.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 1.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.3 | 0.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 1.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.3 | 7.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.3 | 0.5 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.3 | 0.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 4.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 1.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 1.6 | GO:0051645 | Golgi localization(GO:0051645) |
0.3 | 1.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.3 | 0.8 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.3 | 1.0 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
0.3 | 0.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 0.5 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 0.5 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.3 | 1.0 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.3 | 3.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.3 | 1.0 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.3 | 1.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 1.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 0.8 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 0.8 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.3 | 1.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 0.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 1.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.2 | 1.7 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.2 | 1.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 3.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 0.7 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.2 | 0.7 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.7 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 4.4 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 5.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 2.0 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 1.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 1.9 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 1.0 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 | 1.7 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.2 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.7 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.2 | 1.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 1.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.2 | 1.2 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 1.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.2 | 1.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.2 | 0.5 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
0.2 | 0.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.2 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.2 | 0.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.2 | 0.7 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 1.6 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 1.1 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.2 | 0.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.5 | GO:0009838 | abscission(GO:0009838) |
0.2 | 4.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 2.9 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 0.7 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.2 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 1.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 2.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 0.9 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.2 | 0.2 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 1.1 | GO:0000237 | leptotene(GO:0000237) |
0.2 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 1.3 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.2 | 0.2 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 5.2 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.2 | 0.6 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
0.2 | 0.2 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.2 | 4.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 2.5 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.2 | 0.6 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 2.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.2 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.2 | 0.4 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 2.5 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.2 | 0.4 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 0.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 1.0 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.2 | 0.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.2 | 1.9 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 2.7 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 1.0 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.2 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 1.0 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.2 | 1.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 0.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 0.4 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 1.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 1.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.2 | 1.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 0.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 0.4 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.2 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.2 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 1.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.4 | GO:0071332 | response to fructose(GO:0009750) cellular response to fructose stimulus(GO:0071332) |
0.2 | 0.4 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.2 | 0.2 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 0.8 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.2 | 1.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 0.7 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.2 | 0.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 2.4 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.2 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 2.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.2 | 0.2 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 0.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 0.2 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 0.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.2 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 1.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.2 | 0.7 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 2.0 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 0.4 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.2 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.4 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.2 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 0.5 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.2 | 0.2 | GO:0032329 | serine transport(GO:0032329) |
0.2 | 0.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.2 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 2.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.2 | 0.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 1.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.7 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.2 | 8.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.2 | 1.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 1.1 | GO:0070203 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.2 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.2 | 0.2 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.2 | 0.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.2 | 0.2 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 0.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.5 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 1.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.2 | 0.2 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 1.6 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.2 | 0.2 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.2 | 0.2 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.2 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.2 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.2 | 1.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 1.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 0.8 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 1.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 3.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.2 | 2.5 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.5 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 0.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 1.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.2 | 0.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 1.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.2 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.2 | 0.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 1.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.2 | 7.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.2 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.7 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.2 | 0.2 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.2 | 0.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.2 | 0.5 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 0.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.2 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.6 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.2 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 0.5 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 0.8 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.8 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 1.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.5 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.2 | 2.9 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.2 | 1.4 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 1.4 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.8 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 1.4 | GO:0042026 | protein refolding(GO:0042026) |
0.2 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.2 | 0.2 | GO:0043134 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
0.2 | 1.4 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.2 | 0.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 0.5 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.3 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 0.2 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
0.2 | 1.4 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.2 | 3.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.2 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.3 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.2 | 0.3 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 0.5 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 1.8 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.2 | 2.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.2 | 0.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 0.5 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.2 | 0.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 1.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.3 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 1.6 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 1.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 1.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 0.3 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.1 | 0.3 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 1.3 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.1 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 5.2 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 2.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.7 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 1.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 | 0.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.9 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.7 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 1.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.3 | GO:0045623 | negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) |
0.1 | 4.5 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.6 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.1 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.1 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.6 | GO:0060613 | fat pad development(GO:0060613) |
0.1 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.1 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.1 | 0.7 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.1 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.7 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 1.8 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 1.2 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.3 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.1 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 0.3 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.4 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 4.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 2.1 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.1 | 0.8 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.3 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.9 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.5 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 0.4 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 0.3 | GO:0051029 | rRNA transport(GO:0051029) |
0.1 | 0.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.5 | GO:1902403 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 1.1 | GO:0070741 | response to interleukin-6(GO:0070741) cellular response to interleukin-6(GO:0071354) |
0.1 | 3.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 5.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 1.1 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.2 | GO:0018904 | ether metabolic process(GO:0018904) |
0.1 | 0.9 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.4 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.1 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.1 | 0.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.4 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.1 | 0.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.8 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.4 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 1.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 1.8 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.7 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.5 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.6 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 1.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 2.8 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.2 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.6 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 1.6 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.8 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 1.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.5 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.1 | 0.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 0.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.1 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.9 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 0.9 | GO:0016556 | mRNA modification(GO:0016556) |
0.1 | 1.0 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.3 | GO:0044838 | cell quiescence(GO:0044838) |
0.1 | 0.1 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.1 | 0.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.3 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 0.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 4.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 4.0 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.1 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 4.8 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 1.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 1.7 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 0.1 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 0.6 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.2 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.1 | 1.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 2.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 1.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.1 | 0.2 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.4 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 1.0 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.6 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 1.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.1 | 0.1 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.1 | 0.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.5 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.1 | 0.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.1 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.5 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.4 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 1.4 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.2 | GO:0072367 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.4 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 0.1 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.1 | 0.4 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.1 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.1 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.2 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.1 | 1.0 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.1 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.4 | GO:0016139 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.1 | 0.8 | GO:0090231 | regulation of spindle checkpoint(GO:0090231) |
0.1 | 0.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.5 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 0.9 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 2.2 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
0.1 | 0.2 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.1 | 0.5 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.1 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 2.6 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.1 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.1 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.1 | 0.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 0.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 2.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 0.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.3 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 1.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.4 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.1 | 0.2 | GO:0014901 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.1 | 0.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 0.4 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.3 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.1 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.4 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 1.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.1 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.1 | 0.3 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.2 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) |
0.1 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 3.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 0.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.1 | 0.1 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 1.0 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.7 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.4 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 1.0 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.9 | GO:0051904 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 | 0.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.1 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 1.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 2.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 1.4 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.5 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 2.7 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
0.1 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 1.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 1.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.8 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 0.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.1 | 1.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.2 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.2 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.5 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.5 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.1 | 0.6 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.1 | 0.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.7 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.7 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.4 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.1 | 0.1 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) tetrahydrofolate biosynthetic process(GO:0046654) |
0.1 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.3 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.4 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.1 | 1.3 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 2.0 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.1 | 0.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) |
0.1 | 0.3 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.1 | 0.4 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.1 | 0.1 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 0.5 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.2 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.1 | 0.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.3 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.1 | GO:0002719 | negative regulation of cytokine production involved in immune response(GO:0002719) |
0.1 | 0.5 | GO:0070633 | transepithelial transport(GO:0070633) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.1 | GO:0071312 | cellular response to alkaloid(GO:0071312) |
0.1 | 0.3 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.1 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.1 | 0.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.3 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.1 | 1.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 1.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.1 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 1.6 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 3.5 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.2 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.1 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.1 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.4 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.1 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.1 | 0.2 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 1.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 1.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.2 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.1 | 0.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.3 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.9 | GO:0048741 | skeletal muscle fiber development(GO:0048741) |
0.1 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.1 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.3 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.3 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.8 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.1 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 1.5 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.1 | 0.3 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.3 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 2.1 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 1.6 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 2.3 | GO:0015758 | glucose transport(GO:0015758) |
0.1 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.1 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
0.1 | 1.5 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.1 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 0.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 0.7 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.2 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.1 | 0.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.1 | 0.3 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.4 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 0.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 0.4 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.1 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.1 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.0 | 0.0 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.0 | 0.4 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.4 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.0 | 0.2 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.0 | 0.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.2 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.1 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.0 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.0 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.0 | 0.0 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.2 | GO:0038202 | TORC1 signaling(GO:0038202) regulation of TORC1 signaling(GO:1903432) negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.8 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.0 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
0.0 | 0.1 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.0 | 0.6 | GO:0098581 | detection of external biotic stimulus(GO:0098581) |
0.0 | 0.1 | GO:0006971 | hypotonic response(GO:0006971) |
0.0 | 0.1 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.0 | 0.2 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.0 | 0.4 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.3 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.0 | 0.4 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.0 | 0.0 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.0 | 0.0 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
0.0 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) |
0.0 | 0.2 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
0.0 | 0.0 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.0 | 0.0 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.0 | 0.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:1902932 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) positive regulation of alcohol biosynthetic process(GO:1902932) |
0.0 | 0.3 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.0 | 0.1 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 0.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.0 | 0.3 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.0 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.0 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.0 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.0 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.5 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.0 | 1.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.2 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.0 | 0.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.0 | 0.0 | GO:0016577 | histone demethylation(GO:0016577) histone lysine demethylation(GO:0070076) histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.0 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.3 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.0 | 0.2 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.0 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.0 | 0.3 | GO:0007099 | centriole replication(GO:0007099) |
0.0 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.0 | 0.3 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.0 | 0.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.0 | 0.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.1 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 7.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0051342 | protein maturation by protein folding(GO:0022417) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.0 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.1 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.2 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.6 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.4 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.0 | 0.2 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 2.8 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.1 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.0 | 0.3 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.0 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.0 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 2.0 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.8 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.1 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.0 | 0.1 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.5 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 1.1 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.0 | 0.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.7 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.1 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.0 | 0.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.4 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.0 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.2 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.0 | 0.0 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.0 | 0.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.1 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) |
0.0 | 0.1 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.1 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.0 | GO:0032400 | melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.1 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.0 | 0.0 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.0 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.0 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.3 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.0 | 0.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.1 | GO:0002374 | cytokine secretion involved in immune response(GO:0002374) |
0.0 | 0.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:1903748 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
0.0 | 0.2 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.0 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.0 | 0.0 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 2.1 | GO:0010876 | lipid localization(GO:0010876) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.1 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.0 | 0.7 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 1.7 | GO:0098779 | macromitophagy(GO:0000423) mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.0 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.0 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.0 | 0.2 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.0 | 0.1 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.0 | 0.0 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.1 | GO:0080111 | DNA demethylation(GO:0080111) |
0.0 | 0.0 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 0.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.0 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0071824 | protein-DNA complex subunit organization(GO:0071824) |
0.0 | 0.0 | GO:0042168 | heme metabolic process(GO:0042168) |
0.0 | 0.0 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.0 | 0.0 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.0 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 0.0 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.2 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.0 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.0 | 0.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.0 | 0.9 | GO:0048193 | Golgi vesicle transport(GO:0048193) |
0.0 | 0.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0043090 | amino acid import(GO:0043090) |
0.0 | 0.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.0 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.2 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
0.0 | 0.1 | GO:0032602 | chemokine production(GO:0032602) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.3 | GO:0006818 | hydrogen transport(GO:0006818) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.1 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.0 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.0 | 0.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.0 | 0.0 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:0002215 | defense response to nematode(GO:0002215) |
0.0 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.3 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.0 | 0.1 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.0 | 0.3 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.7 | GO:0051262 | protein tetramerization(GO:0051262) |
0.0 | 2.0 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.0 | 0.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0010324 | membrane invagination(GO:0010324) |
0.0 | 0.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0044783 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
0.0 | 0.0 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.0 | 0.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 0.2 | GO:0031623 | receptor internalization(GO:0031623) |
0.0 | 0.1 | GO:0009063 | cellular amino acid catabolic process(GO:0009063) |
0.0 | 0.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.1 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.2 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.5 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.1 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.0 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.0 | 0.0 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.2 | GO:0045471 | response to ethanol(GO:0045471) |
0.0 | 0.0 | GO:2000108 | positive regulation of leukocyte apoptotic process(GO:2000108) |
0.0 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.5 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.0 | 0.1 | GO:0043501 | skeletal muscle adaptation(GO:0043501) |
0.0 | 0.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.3 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.0 | 0.0 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.0 | 0.0 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 1.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.0 | 0.0 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.0 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.0 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.4 | GO:0033141 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.3 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.2 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.0 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.0 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.0 | 0.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.2 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.1 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.0 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.0 | GO:0071838 | cell proliferation in bone marrow(GO:0071838) regulation of cell proliferation in bone marrow(GO:0071863) |
0.0 | 0.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.0 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.0 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.0 | 0.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.2 | GO:0016925 | protein sumoylation(GO:0016925) |
0.0 | 0.0 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.0 | 0.0 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.1 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.0 | 0.2 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.0 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.0 | 0.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.0 | 0.0 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.0 | 2.8 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.0 | 0.1 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.0 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.0 | 0.1 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.0 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 5.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.3 | 9.1 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.3 | 3.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.3 | 3.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.2 | 4.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.9 | 2.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.8 | 2.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.8 | 4.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.8 | 3.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.7 | 8.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 5.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.7 | 4.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.7 | 3.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.6 | 0.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.6 | 1.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.6 | 3.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 1.2 | GO:0042585 | germinal vesicle(GO:0042585) |
0.6 | 4.1 | GO:0042627 | chylomicron(GO:0042627) |
0.5 | 2.2 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 1.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.5 | 2.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 3.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 1.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.5 | 0.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.5 | 1.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.5 | 2.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.5 | 1.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 2.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.4 | 1.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 2.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.4 | 0.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 2.0 | GO:0097433 | dense body(GO:0097433) |
0.4 | 1.2 | GO:0031523 | Myb complex(GO:0031523) |
0.4 | 8.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 2.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 1.2 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 1.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 1.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.4 | 1.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.4 | 1.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 1.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.4 | 4.0 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 1.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 1.4 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.3 | 1.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 5.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 0.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.3 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 2.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 2.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 6.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 2.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 2.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 0.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 1.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 4.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.3 | 1.7 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 0.9 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
0.3 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 1.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 1.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 1.1 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 1.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.3 | 0.8 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 1.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 2.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
0.3 | 3.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 3.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.3 | 3.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 0.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 2.5 | GO:0008278 | cohesin complex(GO:0008278) |
0.3 | 1.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.3 | 2.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 1.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 1.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.2 | 1.4 | GO:0005818 | aster(GO:0005818) |
0.2 | 0.7 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 1.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 3.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 1.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.1 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.6 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 2.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 0.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.2 | 1.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 0.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.6 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 3.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 0.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 2.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.2 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 2.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 6.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 4.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 3.2 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.9 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.9 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 4.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.2 | 7.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 10.0 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 2.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 2.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 3.0 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 1.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 2.8 | GO:0005901 | caveola(GO:0005901) |
0.2 | 0.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 1.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.2 | 0.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 7.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 1.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.2 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 2.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 1.5 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 5.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 1.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 8.3 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.2 | 0.5 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 2.3 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 0.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 0.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.2 | 2.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 0.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 2.7 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 41.3 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 2.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 5.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.6 | GO:0071010 | prespliceosome(GO:0071010) |
0.1 | 19.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 2.1 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.1 | 0.4 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 6.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 2.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.8 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.3 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.4 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.1 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 2.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 2.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 0.6 | GO:0002141 | stereocilia ankle link(GO:0002141) |
0.1 | 4.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 1.9 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 2.6 | GO:0005903 | brush border(GO:0005903) |
0.1 | 1.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 1.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.1 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.7 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.1 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 0.5 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 3.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 1.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 0.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 6.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 1.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.1 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 1.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 1.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 3.9 | GO:0005844 | polysome(GO:0005844) |
0.1 | 3.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 0.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 13.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 5.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.3 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 5.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 1.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 3.9 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.1 | 4.5 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.8 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.7 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 9.9 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.1 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 4.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 7.1 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 5.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 2.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 1.8 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 0.5 | GO:0045202 | synapse(GO:0045202) |
0.1 | 2.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 3.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 1.9 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.9 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 1.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 5.9 | GO:0030496 | midbody(GO:0030496) |
0.1 | 1.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 6.9 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 5.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 2.0 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 1.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.5 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.3 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 2.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 3.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 25.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 4.7 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 3.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 5.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 1.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.1 | 1.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 64.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 30.9 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 52.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 2.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 2.6 | GO:0055029 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
0.1 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.1 | GO:0043601 | nuclear replisome(GO:0043601) |
0.1 | 46.4 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 1.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.1 | 2.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.2 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.2 | GO:1902911 | protein kinase complex(GO:1902911) |
0.1 | 0.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 3.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.1 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 8.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:1990752 | microtubule end(GO:1990752) |
0.0 | 0.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.0 | 0.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 2.4 | GO:0012505 | endomembrane system(GO:0012505) |
0.0 | 0.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 1.0 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.0 | 0.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.3 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.0 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 0.0 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 1.3 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 4.4 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 31.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 1.0 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.9 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 11.6 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.0 | 0.0 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 3.9 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 1.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.1 | GO:0031968 | organelle outer membrane(GO:0031968) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 5.9 | GO:0005773 | vacuole(GO:0005773) |
0.0 | 0.2 | GO:0002102 | podosome(GO:0002102) |
0.0 | 6.8 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.1 | GO:0098588 | bounding membrane of organelle(GO:0098588) |
0.0 | 0.5 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 75.4 | GO:0005737 | cytoplasm(GO:0005737) |
0.0 | 0.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.4 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.0 | 20.3 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.0 | 0.1 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.0 | 0.2 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.6 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.6 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.0 | 0.0 | GO:0030424 | axon(GO:0030424) |
0.0 | 0.0 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.5 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.2 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 8.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.0 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 36.3 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0043230 | extracellular organelle(GO:0043230) |
0.0 | 0.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 4.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 4.4 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.0 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 2.8 | GO:0016020 | membrane(GO:0016020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.7 | 5.0 | GO:0055100 | adiponectin binding(GO:0055100) |
1.6 | 1.6 | GO:0070538 | oleic acid binding(GO:0070538) |
1.5 | 4.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
1.4 | 1.4 | GO:0031432 | titin binding(GO:0031432) |
1.4 | 4.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.3 | 3.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.3 | 1.3 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.3 | 5.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
1.2 | 3.6 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.2 | 6.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.1 | 4.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.0 | 4.0 | GO:0015232 | heme transporter activity(GO:0015232) |
1.0 | 3.9 | GO:0009374 | biotin binding(GO:0009374) |
1.0 | 3.8 | GO:0051425 | PTB domain binding(GO:0051425) |
1.0 | 3.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 6.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 3.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.9 | 3.7 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.9 | 8.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.9 | 2.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.8 | 3.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.8 | 2.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.8 | 2.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.8 | 2.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.8 | 2.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.7 | 3.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.7 | 2.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.7 | 2.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 2.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.7 | 0.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.7 | 3.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.7 | 2.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.7 | 13.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.7 | 2.8 | GO:0015265 | urea channel activity(GO:0015265) |
0.7 | 2.8 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 2.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.7 | 4.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 2.7 | GO:0050693 | LBD domain binding(GO:0050693) |
0.7 | 2.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 3.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 2.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.6 | 1.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 3.6 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.6 | 1.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 0.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.6 | 1.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 3.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.6 | 1.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.6 | 9.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.6 | 1.7 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.6 | 1.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 1.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.5 | 1.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.5 | 2.2 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.5 | 3.8 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 4.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.5 | 2.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.5 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.5 | 1.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 2.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 3.0 | GO:0050733 | RS domain binding(GO:0050733) |
0.5 | 4.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.5 | 6.4 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.5 | 3.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.5 | 3.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.5 | 3.8 | GO:0060229 | lipase activator activity(GO:0060229) |
0.5 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 5.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 1.8 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 0.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.4 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 6.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.4 | 1.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.4 | 2.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 1.3 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 3.8 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 3.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.4 | 6.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.4 | 6.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 6.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.4 | 2.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 2.4 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.4 | 2.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 1.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 3.6 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 1.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.4 | 3.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.4 | 2.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 2.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 4.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.4 | 5.0 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.4 | 1.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 1.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 1.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.4 | 3.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.4 | 1.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 1.9 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 1.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 1.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 0.7 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.4 | 0.7 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 1.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.3 | 0.3 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.3 | 1.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.3 | 1.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 1.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 1.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 1.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.3 | 11.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 1.0 | GO:0034858 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 1.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.3 | 1.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 2.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.3 | 2.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.6 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 5.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 9.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.3 | 3.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 0.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.3 | 1.2 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.3 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 1.8 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 2.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 0.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.3 | 0.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.3 | 0.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 0.3 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 1.2 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 2.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.3 | 1.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 1.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 1.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 1.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.3 | 0.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 0.8 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 1.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 1.6 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.3 | 2.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 1.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 12.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 5.2 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.3 | 4.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 2.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 0.8 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.3 | 0.5 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.3 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 2.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 0.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.7 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 2.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 3.0 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 3.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 16.7 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 2.4 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.2 | GO:0004064 | arylesterase activity(GO:0004064) |
0.2 | 2.8 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.2 | 1.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.2 | 0.9 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 1.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 1.2 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 1.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 1.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 0.7 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 10.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 1.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 1.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 1.5 | GO:0018632 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 1.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 0.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 1.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 0.2 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
0.2 | 2.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 2.3 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 0.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 3.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 3.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 2.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 1.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.2 | 2.8 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 1.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 1.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 1.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 1.0 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 2.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.6 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.8 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.2 | 1.4 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.2 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.2 | 1.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 2.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 1.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 5.7 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 1.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.2 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.2 | 0.9 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
0.2 | 0.6 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 4.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 1.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.5 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.2 | 1.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 0.5 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 5.4 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.5 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 4.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 0.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.2 | 0.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.2 | 0.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.2 | 4.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 3.0 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.2 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 1.4 | GO:0018447 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 7.4 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.2 | 0.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 3.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 2.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 9.0 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.2 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 2.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 0.5 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 2.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 2.0 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.2 | 1.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 0.3 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 3.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 2.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.2 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 1.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.3 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.2 | 6.2 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.2 | 3.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 3.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 1.1 | GO:0018855 | acyl-CoA ligase activity(GO:0003996) 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.2 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.5 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.5 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.2 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 2.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 1.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.6 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 2.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 4.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 3.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 3.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 1.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 1.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 1.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 3.4 | GO:0052712 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 1.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 1.2 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 3.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 1.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.1 | 0.4 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.5 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 2.8 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 10.6 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.1 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 2.2 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 1.5 | GO:0052859 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 0.1 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.8 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 1.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 2.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 4.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 4.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 9.1 | GO:0005506 | iron ion binding(GO:0005506) |
0.1 | 0.9 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 5.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) alcohol transmembrane transporter activity(GO:0015665) |
0.1 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.7 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 1.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 1.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.6 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.1 | 0.1 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 4.3 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.1 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.1 | 0.6 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 1.2 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.2 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 3.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.6 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 1.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.3 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.8 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 2.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.5 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.5 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 15.1 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.1 | 0.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.1 | 0.3 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.0 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.1 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.1 | 1.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 5.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.6 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 4.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 2.7 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 1.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 17.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 0.2 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
0.1 | 0.4 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 3.1 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.1 | 0.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 1.8 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.1 | 1.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 6.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 1.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 0.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.6 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.6 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.8 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 2.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.1 | GO:0043141 | 5'-3' DNA helicase activity(GO:0043139) ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.6 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.2 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.1 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.5 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 2.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.5 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.1 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 2.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.2 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 0.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 4.3 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 2.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 4.7 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 0.4 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 2.5 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.4 | GO:0015370 | solute:sodium symporter activity(GO:0015370) |
0.1 | 0.6 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.1 | 0.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.1 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 17.4 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.1 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 1.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 0.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 9.1 | GO:0044389 | ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 1.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 2.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 1.4 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.1 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 1.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.1 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.1 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.1 | 0.2 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.3 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.1 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 4.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.9 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 1.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 1.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 1.9 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 2.8 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.2 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.7 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.2 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 0.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.8 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 3.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 4.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 3.1 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.8 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 4.6 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.3 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.0 | 1.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.0 | 0.0 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.0 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 4.2 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.0 | 0.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.8 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.0 | 1.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.8 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 2.1 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.0 | 0.3 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.4 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.0 | 1.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 3.0 | GO:0042277 | peptide binding(GO:0042277) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.0 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 2.6 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.0 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.0 | 0.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 25.8 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 3.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.2 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.2 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 0.1 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.0 | 0.8 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.2 | GO:0042562 | hormone binding(GO:0042562) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 2.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.5 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 0.7 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 1.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 2.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 0.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 24.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 4.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.5 | 17.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 3.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 11.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 2.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 10.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 5.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 2.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 6.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 5.6 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 9.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 8.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 2.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 3.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 5.3 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 6.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 0.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 15.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 9.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.2 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.2 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 2.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 5.4 | PID ATM PATHWAY | ATM pathway |
0.2 | 2.6 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 5.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 4.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 4.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.2 | 1.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.9 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 4.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 2.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 0.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 1.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 1.4 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 4.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 3.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 1.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 0.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 5.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 5.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 5.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 4.5 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 4.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 4.0 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.4 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 2.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 3.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.9 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 0.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.2 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.0 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.0 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 6.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 1.1 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 2.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 2.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.7 | 12.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.6 | 9.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 8.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 1.6 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.5 | 12.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.5 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 9.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 5.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 6.7 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.5 | 8.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.5 | 4.2 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.5 | 4.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 4.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.4 | 1.8 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.4 | 10.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 3.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 8.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.4 | 3.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.3 | 10.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 4.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 2.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 0.6 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 5.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 8.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 2.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 4.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 4.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 2.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 2.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 4.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 3.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 3.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 4.3 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.3 | 3.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 3.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.3 | 8.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.3 | 5.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 2.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 1.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 3.6 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 6.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 3.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 0.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 3.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.2 | 1.4 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 5.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 1.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 3.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.2 | 3.1 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 2.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 10.1 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 6.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 3.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 3.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 4.5 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 2.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 2.7 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 1.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 4.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 21.1 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 5.7 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.2 | 4.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 2.7 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.2 | 2.0 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 3.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 7.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 2.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.2 | 6.8 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 4.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 2.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 1.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 1.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 3.9 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 1.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 6.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 5.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.2 | 1.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 2.2 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 4.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 2.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 2.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.9 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 6.5 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.8 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 0.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 1.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 7.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 2.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 4.7 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 2.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 1.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 2.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.5 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.9 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 0.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 1.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.8 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.1 | 1.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 8.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 4.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 1.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 2.5 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.1 | 0.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 2.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 5.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 1.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 0.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.9 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.2 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 0.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.7 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.1 | 2.0 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 5.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 2.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 5.0 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.8 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 6.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.8 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 2.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.8 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.2 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 0.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.0 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 1.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |